PHVS SCHEDULE 13G/A: SEC filing
General Atlantic entities
Filed with the SEC on · accession 0000950142-26-002357
PHVS filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Aug 14, 2026. A report the company filed with the SEC (the US market regulator). The stock moved +3.2% by the first close after the filing.
Summary of the filing
General Atlantic entities filed a joint acquisition statement (Schedule 13G/A) regarding their passive ownership stake in Pharvaris N.V. The filing is an administrative amendment confirming joint filing responsibility among the General Atlantic affiliates.
Key details
How PHVS stock reacted
Close before
$34.04
Aug 13, 2026
First close after
+3.23%
$35.14
5 trading days
+6.90%
$36.39
Since filing
+1.03%
$34.39
✦ Ask GOAX AI about this filing — what it means for PHVS, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for PHVS?
Click hereFrequently asked questions
What did PHVS file with the SEC on Aug 14, 2026?
PHVS filed a SCHEDULE 13G/A (SEC filing). General Atlantic entities filed a joint acquisition statement (Schedule 13G/A) regarding their passive ownership stake in Pharvaris N.V. The filing is an administrative amendment confirming joint filing responsibility among the General Atlantic affiliates.
How do I read a SCHEDULE 13G/A?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).
How did PHVS stock react to this filing?
PHVS closed at $34.04 before the filing and $35.14 on Aug 14, 2026 (+3.23%). Five trading days later: $36.39 (+6.90%).
Other PHVS SEC filings
- 6-K · SEC filingSep 8, 2026
- 6-K · Fda approvalSep 8, 2026
- 6-K · SEC filingAug 12, 2026
- 144 · Insider sale plannedJun 30, 2026
- 144 · Insider sale plannedJun 30, 2026
- 144 · Insider sale plannedJun 30, 2026
- 144 · Insider sale plannedJun 29, 2026
- 144 · Insider sale plannedJun 29, 2026
- 144 · Insider sale plannedJun 29, 2026
- 144 · Insider sale plannedJun 26, 2026
Get alerts when PHVS files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days